Australasian Journal of Dermatology

Article	Citations
COVID‐19 and the use of immunomodulatory and biologic agents for severe cutaneous disease: An Australian/New Zealand consensus statement	42
Advice regarding COVID‐19 and use of immunomodulators, in patients with severe dermatological diseases	27
Poster Presentations	23
Dermoscopy, confocal microscopy and optical coherence tomography features of main inflammatory and autoimmune skin diseases: A systematic review	22
Repigmentation of vitiligo with oral baricitinib	21
Evaluation of the efficacy of cysteamine cream compared to hydroquinone in the treatment of melasma: A randomised, double‐blinded trial	18
Rosacea and the gastrointestinal system	17
Carbon footprint of dermatologic surgery	17
Tildrakizumab in the treatment of moderate‐to‐severe hidradenitis suppurativa	17
SDRIFE‐like rash associated with COVID‐19, clinicopathological correlation	16
Tildrakizumab as a potential long‐term therapeutic agent for severe Hidradenitis Suppurativa: A 15 months experience of an Australian institution	15
Successful secukinumab treatment of active bullous pemphigoid and chronic severe psoriasis: a case report	15
SARS‐CoV‐2 (COVID‐19) vaccination in dermatology patients on immunomodulatory and biologic agents: Recommendations from the Australasian Medical Dermatology Group	15
Cutaneous manifestations of viral outbreaks	14
Pityriasis rosea‐like eruption revealing COVID‐19	14
Paediatric and Adolescent Dermatology	13
Probiotic mixture reduces gut inflammation and microbial dysbiosis in children with atopic dermatitis	13
An unusual presentation of pemphigus foliaceus following COVID‐19 vaccination	13
Practice guidelines for teledermatology in Australia	13
Management of hypertrophic scars in adults: A systematic review and meta‐analysis	12
Efficacy of topical Calendula officinalis on prevalence of radiation‐induced dermatitis: A randomised controlled trial	12
Tissue eosinophil levels as a marker of disease severity in bullous pemphigoid	11
Defining the incidence of cutaneous squamous cell carcinoma in coastal NSW Australia	11
Psoriasis: A bibliometric analysis in the Arab World (2004–2019)	11
Extragenital lichen sclerosus: A comprehensive review	11

A review of actinic keratosis, skin field cancerisation and the efficacy of topical therapies	11
Prospective study of pigmented lesions managed by shave excision with no deep margin transection of melanomas	11
Tildrakizumab in the treatment of PASH syndrome: A potential novel therapeutic target	11
Legal and ethical considerations of artificial intelligence in skin cancer diagnosis	11
A narrative review of the roles of topical permethrin and oral ivermectin in the management of infantile scabies	11
Forming diagnostic criteria for vulvar lichen planus	10
Is methotrexate hepatotoxicity associated with cumulative dose? A systematic review and meta‐analysis	10
Cutaneous leiomyosarcoma: dermal and subcutaneous	10
Dermoscopic patterns of intradermal naevi	10
Successful treatment of chronic severe alopecia areata with abrocitinib	10
Effective treatment of oral lichen planus with the JAK inhibitor baricitinib	10
Dupilumab‐associated psoriasis and psoriasiform dermatitis in patients with atopic dermatitis	10
VEXAS syndrome: A dermatological perspective	9
Necrotic acral lesions and lung failure in a fatal case of COVID‐19	9
A retrospective review of UVA1 treatment: An Australian experience from a single centre	9
Combination treatment with monoclonal antibodies: Secukinumab, benralizumab and dupilumab for the combined management of psoriasis and severe asthma	9
Systematic review of sirolimus in dermatological conditions	8
Factors associated with high Altmetric Attention Score in dermatology research	8
Topical simvastatin–cholesterol for disseminated superficial actinic porokeratosis: An open‐label, split‐body clinical trial	8
Quality of life of women with untreated vulval lichen sclerosus assessed with vulval quality of life index (VQLI)	8
Idiopathic Granulomatous Mastitis and Erythema nodosum – A Unifying Pathophysiology?	8
Congenital melanocytic naevi: An up‐to‐date overview	8
Mucormycosis with cutaneous involvement. A retrospective study of 115 cases at a tertiary care hospital in Mexico	8
Secukinumab use in the treatment of Netherton's syndrome	8
Clinical characteristics and predictive factors of erythema nodosum in granulomatous lobular mastitis	8
Successful treatment of calciphylaxis in a renal transplant recipient with combination of intralesional sodium thiosulphate, intravenous sodium thiosulphate and fish skin graft	8
Clinical and histopathological features of onychopapilloma in an Australian setting: A case series of 50 patients	7
Onychopapilloma presenting as longitudinal melanonychia: A case report and literature review	7
Misdiagnoses and barriers to care in hidradenitis suppurativa: A patient survey	7
Dermoscopy and reflectance confocal microscopy of intraepidermal Merkel cell carcinoma	7
Topical epigallocatechin‐3‐gallate in the treatment of vitiligo	7
Novel combination biologic therapy for recalcitrant psoriasis and psoriatic arthritis in a medically complex patient	7
Treatment of granuloma annulare with tofacitinib	7
Toxic epidermal necrolysis and Stevens‐Johnson syndrome after COVID‐19 infection and vaccination	7
Epidemiology of cutaneous sebaceous carcinoma	7
Ultraviolet filter, fragrance and preservative allergens in New Zealand sunscreens	7
Characteristics of 637 melanomas documented by 27 general practitioners on the Skin Cancer Audit Research Database	7
Cutaneous‐group histiocytoses associated with myeloid malignancies: A systematic review of 102 cases	7
Two cases of vitiligo vulgaris treated with topical Janus kinase inhibitor delgocitinib	7
Cutaneous manifestations and dermatological sequelae of Covid‐19 infection compared to those from other viruses	7
Acral lentiginous melanoma: Clinicopathologic and survival differences according to tumour location	7
A case of treatment‐resistant pityriasis rubra pilaris responsive to secukinumab	7
A case of toxic epidermal necrolysis after ChAdOx1 nCov‐19 (AZD1222) vaccination	6
Efficacy of topical versus intradermal injection of Tranexamic Acid In Egyptian melasma Patients: A randomised clinical trial	6
Different epigenome regulation and transcriptome expression of CD4+ and CD8+ T cells from monozygotic twins discordant for psoriasis	6
Challenges and pitfalls between lichen planus pemphigoides and bullous lichen planus	6
The impact of incomplete clinical information and initial biopsy technique on the histopathological diagnosis of cutaneous melanoma	6
A machine‐learning modified CART algorithm informs Merkel cell carcinoma prognosis	6
Oral mycophenolate mofetil in the treatment of acquired dermal macular hyperpigmentation: An open‐label pilot study	6
Use of narrowband ultraviolet B (NBUVB) in paediatric psoriasis: A systematic literature review and meta‐analysis	6

BAP1‐inactivated melanocytic tumour with borderline histopathological features (BAP1‐inactivated melanocytoma): A case report and a reappraisal	6
Vulval lichen sclerosus: An Australasian management consensus	6
Re Facial aesthetic injections in clinical practice: Pretreatment and post‐treatment consensus recommendations to minimise adverse outcome Region‐specific changes in line with the Covid‐19 pandemic	6
Development and validation of a new method for potential use of Psoriasis Area and Severity Index in teledermatology	6
Successful treatment of pityriasis rubra pilaris with tildrakizumab	6
Epidemiological, clinical, pathological and genetic characteristics of epidermolysis bullosa in New Zealand	6
Dupilumab successfully treated refractory bullous pemphigoid with early clinical manifestations imitating atopic dermatitis: A case letter	6
Characteristics, treatment and outcomes of 589 melanoma patients documented by 27 general practitioners on the Skin Cancer Audit Research Database	6
Thalidomide for prevention of camrelizumab‐induced reactive cutaneous capillary endothelial proliferation	6
Medical Dermatology	6
Effective treatment of disseminated superficial actinic porokeratosis using a novel topical cholesterol/simvastatin combination cream	6
Teledermatology for patient management, dermatology education and research during the COVID‐19 pandemic	6
Cutaneous mastocytosis: A dermatological perspective	6
Successful treatment of vulvovaginal lichen planus with tildrakizumab: A case series of 24 patients	6
Subacute cutaneous lupus erythematosus induced by PD‐1 Inhibitor therapy: two case reports and literature review	6
Differences in the skin microbial community between patients with active and stable vitiligo based on 16S rRNA gene sequencing	5
Successful management of treatment resistant nail psoriasis with tildrakizumab	5
Appropriate indication and procedure for random skin biopsy in the diagnosis of intravascular large B‐cell lymphoma	5
Epidermolysis Bullosa Pruriginosa successfully treated with concomitant topical and systemic agents	5
Ultrasound‐guided de‐roofing of epithelialised tunnels of hidradenitis suppurativa	5
Five years of dermatological disease requiring specialist care in the Kimberley region of Western Australia	5
Disseminated superficial actinic porokeratosis following hydroxyurea treatment: A case report	5
Cutaneous adverse reactions following the Pfizer/BioNTech COVID‐19 vaccine	5
Dermoscopic features of solitary neurofibroma: A retrospective analysis of 32 cases	5
Segmental stiff skin syndrome (SSS): Clinical case and a brief review	5
Management of chronic hand and foot eczema. An Australia/New Zealand Clinical narrative	5
A CLOSE‐UP guide to capturing clinical images	5
Keratinocyte cancer with incidental perineural invasion: A registry analysis of management and 5‐year outcomes	5
Neutrophilic dermatosis: a new skin manifestation and novel pathogenic variant in a rare autoinflammatory disease	5
Assessment of 5‐Aminolaevulinic Acid Photodynamic Therapy (ALA‐PDT) in Chinese patients with actinic keratosis: Correlation of dermoscopic features with histopathology	5
Dermoscopic features of primary cutaneous amyloidosis in skin of colour: A retrospective analysis of 48 patients from South India	5
Serum level of S100B in vitiligo patients: Is it a marker of disease activity?	5
Allergic contact dermatitis caused by timolol eyedrop application for classic Kaposi sarcoma	5
Australian Teledermatology experience during COVID‐19	5
Ulcerating necrobiosis lipoidica successfully treated with ustekinumab	5
A casemix study of patients seen within an urban Aboriginal Health Service dermatology clinic over a five‐year period	5
Reactive perforating collagenosis successfully treated with dupilumab	5
Dermoscopic features of port‐wine stains: A study of 264 cases	5
Onychomycosis in older adults: The age and associated factors affecting the complete cure rate	5
Association study of transition of laboratory marker levels and transition of disease activity of atopic dermatitis patients treated with dupilumab	5
A long‐term cohort study of acitretin for prevention of keratinocyte carcinoma in solid organ transplant recipients	5
Melanoma/Oncology	5
Growth rate of clinically diagnosed superficial basal cell carcinoma and changes in dermoscopic features over time	5
	5
Is there any association between psoriasis, psoriatic arthritis and thyroid autoimmunity?	5
Risk factors for cytomegalovirus reactivation in autoimmune bullous disease patients on immunosuppressive therapy	4
Cellulitis‐like Sweet Syndrome caused by adalimumab therapy for severe hidradenitis suppurativa	4
Infection with Mycobacterium immunogenum following botulinum toxin injection	4
Multicoloured rainbow pattern in a case of aneurysmal dermatofibroma	4
Multicentric reticulohistiocytosis revealing breast cancer: Report of a case with dermoscopic, radiological and therapeutic aspects	4
Long‐term dupilumab therapy in Netherton syndrome with severe atopic manifestations: Case report and review of the literature	4
Extragenital/extraungueal Bowen disease arising in the absence of field cancerisation is not associated with human papillomavirus infection: Results from a pilot study	4
Mycosis fungoides and Sézary syndrome: Australian clinical practice statement	4
Pseudoglucagonoma syndrome: Description of an ‘Idiopatic’ case	4
Clobetasol propionate 0.05% under occlusion for alopecia areata: Clinical effect and influence on intraocular pressure	4
Nodular lichen myxoedematous: a new adverse event associated with ustekinumab	4
	4
Efficacy of ustekinumab and guselkumab in treatment refractory pityriasis rubra pilaris: A case series	4
Real‐time teledermatology clinics in a tertiary public hospital: A clinical audit	4
Informing a position statement on the use of artificial intelligence in dermatology in Australia	4
Treatment of High Risk Resected Melanoma in Australia: Current Landscape and Practises	4
Medical dermatology	4
S100‐negative indeterminate cell histiocytosis: in an eight‐month‐old boy	4
Fractional carbon dioxide laser for treating hypertrophic scars: A systematic review of randomised trials	4
Scrotal Dowling–Degos disease caused by a novel frameshift variant in gamma‐secretase subunit presenile enhancer gene	4
Merkel cell carcinoma in situ: A systematic review of prognosis and management	4
Acro‐ischemic lesions associated with extremely elevated D‐Dimer in a child during the COVID‐19 pandemic	4
Bullous pemphigoid associated with anti‐programmed cell death protein 1 and anti‐programmed cell death ligand 1 therapy: A case series of 13 patients	4
Impact of COVID‐19 on inpatient dermatology consults in an Australian tertiary hospital	4
A practical guide on the use of imiquimod cream to treat lentigo maligna	4
Nail dermatoscopic (onychoscopic) features of nail lichen planus: A cross‐sectional study	4
Blau syndrome with pulmonary nodule in a child	4
How good is the Australian baseline series at detecting allergic contact dermatitis?	4
Acquired idiopathic generalized anhidrosis diagnosed following mRNA COVID‐19 vaccination—A case series	4
Pyoderma gangrenosum: A review of patient's demographics, disease and treatment in 118 patients	4
Expression of programmed cell death ligand 1 (PD‐L1) at in situ and invasive extramammary Paget’s disease and literature review	4
Highlighting adalimumab as a treatment option for systemic treatment of toxic epidermal necrolysis: A case series from a tertiary specialised burns centre	4
Long‐lasting contact dermatitis in patients with atopic dermatitis or psoriasis	4
Bowel‐associated dermatosis–arthritis syndrome (BADAS)	4
Repigmentation of acrofacial vitiligo with subcutaneous tildrakizumab	4

Pembrolizumab associated Stevens–Johnson syndrome with porokeratosis in a patient in the setting of primary hepatocellular carcinoma	4
Hydroxychloroquine treatment for Alopecia Universalis: Report of six cases	4
Management of multiple trichoepithelioma: A review of pharmacological therapies	4
A case in which paraneoplastic pemphigus and bronchiolitis obliterans are the main manifestations of inflammatory pseudotumour‐like follicular dendritic cell sarcoma	4
Itraconazole in the treatment of basal cell carcinoma: A case‐based review of the literature	4
Biologics/Psoriasis	4
Relationship between PASI and FDLQI in paediatric psoriasis, and treatments used in daily clinical practice	4
Combination treatment of bilateral periocular sebaceous carcinomas with microsatellite instability with neoadjuvant pembrolizumab and Mohs surgery	4
Treatment modalities and risk of adverse events associated with biologic therapy: A 10‐year observational review of the Australasian Psoriasis Registry	4
A case of Wong‐type dermatomyositis treated with rituximab and IVIG	3
Quality of life impact and treatment response in vulval disease: Comparison of 3 common conditions using the Vulval Quality of Life Index	3
Transient hypertriglyceridaemia associated with propranolol for treatment of infantile hemangioma	3
Cutaneous squamous cell carcinoma metastatic to the axilla and groin: Outcomes and prognostic factors	3
Knowledge and attitudes of Australian dermatologists towards sentinel lymph node biopsy for melanoma: a mixed methods study	3
Vulvar malignancy in biopsy‐proven vulval lichen planus: A retrospective review of 105 cases	3
Disseminated phaeohyphomycosis caused by Cyphellophora ludoviensis: A novel case report from Iran	3
Real world experience using Ciclosporin in psoriasis: Efficacy and toxicity in the Australasian Psoriasis Registry	3
Patch testing in New Zealand: Barriers to evidence‐based care	3
Roles of gut‐microbiota and probiotics in chronic urticaria: A systematic review and meta‐analysis	3
The association of anti‐gliadin and anti‐transglutaminase antibodies and chronic plaque psoriasis in Indian patients: Preliminary results of a descriptive cross‐sectional study	3
Baby wipes and nappy rash – what is the relationship? A review	3
Histone deacetylase 1 in patients with alopecia areata and acne vulgaris: An epigenetic alteration	3
Pigmented purpuric dermatoses versus purpuric mycosis fungoides: Clinicopathologic similarities and new insights into dermoscopic features	3
Dermatological services; patient profiling in a rural tertiary hospital	3
Cilioretinal artery occlusion and anterior ischaemic optic neuropathy due to periocular botulinum toxin a injection: A case report	3
The association between hidradenitis suppurativa and male and female infertility: A population‐based study	3
Pseudocystic pilomatricoma: A new variant and review of the literature	3
Nail dystrophy as initial presentation of systemic amyloidosis	3
Histopathological findings in COVID‐19‐induced cutaneous lesions. Clinicopathological correlation of SARS‐CoV‐19 dermatologic patterns: review of the literature	3
Quantifying the ultraviolet radiation emitted by nail curing devices: A descriptive study	3
Multiple lesions of cutaneous focal mucinosis in a patient receiving treatment with tocilizumab: Coincidence or causality?	3
Diagnostic tools used for melanoma: A survey of Australian general practitioners and dermatologists	3
Moisturisers from birth in at‐risk infants of atopic dermatitis – a pragmatic randomised controlled trial	3
Pancreatic adenocarcinoma presenting as subacute cutaneous lupus, tripe palms and acanthosis nigricans maligna	3
A case of disseminate and recurrent infundibulofolliculitis successfully responded to oral doxycycline: A case report	3
Miliaria crystallina induced by idarubicin and all‐trans‐retinoic acid: Two case reports	3
Subcutaneous panniculitis‐like T‐cell lymphoma in a 14‐year‐old female homozygous for HAVCR2 mutation	3
Neoadjuvant intralesional methotrexate in small‐sized cutaneous squamous cell carcinoma: a prospective study in 84 patients	3
Skin metastasis from papillary thyroid carcinoma: A rare case with an unusual clinical presentation	3
First report of cutaneous mycetoma by Paecilomyces variotii and the successful treatment with combined itraconazole and terbinafine along with resection surgeries	3
Hypopigmented mycosis fungoides: A 48‐case retrospective series	3
Prurigo pigmentosa: An institutional retrospective study of 24 patients	3
Childhood granulomatous periorificial dermatitis: Dermoscopy, reflectance confocal microscopy and histopathological correlations	3
Immunotherapy for the treatment of penile intraepithelial neoplasia associated with human papilloma virus type 16 using topical imiquimod and human papilloma virus vaccination	3
Scrutinising the role of simvastatin in a patient of Pachyonychia Congenita with KRT6A gene mutation	3
Efficacy of switching from adalimumab originator to adalimumab biosimilar in moderate to severe psoriasis patients: A Real‐life experience in a tertiary referral centre	3
Erosive pustular dermatosis of the scalp‐like eruption from panitumumab	3
Porokeratoma in the nipple: A case report	3
Successful treatment of idiopathic Harlequin Syndrome with oxybutynin and propranolol	3
Recurrent cutaneous necrotising eosinophilic vasculitis	3
Eruptive vellus hair cysts diagnosed using dermatological imaging technique	3
Inter‐ and intra‐patient heterogeneity of PD‐L1 expression in metastatic melanomas: A retrospective study	3
The role of artificial intelligence language models in dermatology: Opportunities, limitations and ethical considerations	3
Support for a Microbial Basis for Hyperkeratotic Flexural Erythema	3
Nine cases of chronic hand and foot eczema treated with baricitinib	3
A real‐world Australian experience of upadacitinib for the treatment of severe atopic dermatitis	3
Eruptive Bowen's Disease in a patient on pembrolizumab for Hodgkin's lymphoma	3
Clinicopathological characteristics and prognosis of amelanotic acral melanoma: A comparative study with pigmented acral melanoma	3
Comparison of the EUROIMMUN Dermatology Profile ELISA to the novel BIOCHIP Mosaic 7 for the diagnosis of immunobullous skin disease	3
Benefits of skin application of piceatannol—A minireview	3
Increased risk of herpes zoster in patients with psoriasis: A longitudinal follow‐up study using a national sample cohort	3
Hydroxyurea‐induced squamous cell carcinoma	3
Guidance on infection control and plume management with Laser and Energy‐Based Devices taking into consideration COVID‐19	3
Adults with a more extensive body involvement, moderate to extremely severe vitiligo and a prolonged clinical course have an early onset in childhood in addition to other prognostic factors as compare	3
PD‐1 inhibitors for cutaneous squamous cell carcinoma: A meta‐analysis	3
Bullous pemphigoid in a young male during treatment with adalimumab	3
A case of lymphangioma circumscriptum with new reflectance confocal microscopy findings	3
Is pyoderma gangrenosum associated with solid malignancies? Insights from a population‐based cohort study	3
Multi‐drug resistant dermatophyte infections in Western Sydney: A retrospective case series	3
Adult female acne: Clinical characteristics and factors significantly associated with polycystic ovary syndrome	3
Secukinumab treatment demonstrated high drug survival and sustained effectiveness in patients with severe chronic plaque psoriasis: 21‐month analysis in Australian routine clinical practice (SUST	3
Melanoma diagnosis at a specialist dermatology practice without the use of photographic surveillance	3
Secukinumab and infectious adverse effects: A real‐life experience of 63 psoriasis patients	3
Clinical and dermatoscopic characteristics of lichen planus‐like keratosis in a West‐Asian population	3
Severe progressive scarring pembrolizumab‐induced lichen planopilaris in a patient with metastatic melanoma	3
Annular atrophic lichen planus induced by anti‐HER2 antibodies	3
Management of patients with pemphigus vulgaris during the COVID‐19 pandemic: Experience of a second level dermatology center	3
Autoimmune progesterone dermatitis presenting as recurrent, marked angioedema‐like lip changes: An unusual presentation of an uncommon problem	2
Expression of survivin and p53 genes in patients with alopecia areata: A case–control study	2
Two cases of yellow urticaria revealing acute lithiasic biliary disease	2
	2
	2
Why do some patients with vulval lichen sclerosus on long‐term topical corticosteroid treatment experience ongoing poor quality of life?	2
Talimogene laherparepvec resulting in near‐complete response in a patient with treatment‐refractory Merkel cell carcinoma	2
	2
Impact of alopecia areata on subsequent pregnancy rate: A retrospective cohort study	2
Acroangiodermatitis, Mali and Stewart–Bluefarb type: Two additional cases in adolescents	2
Hair and Nails	2
Acute generalised exanthematous pustulosis after initiation of palbociclib therapy for metastatic breast cancer	2
Mental health, insomnia and suicidal ideation during treatment with apremilast	2
Considerations in pre‐treatment testing for Strongyloides stercoralis in an Australian cohort of 159 patients receiving biological therapies	2
Papular acantholytic dyskeratosis	2
Verrucous epidermoid cyst on the back containing high risk human papillomaviruses‐16 and 59	2
Three cases of symmetrical drug‐related intertriginous and flexural exanthema (SDRIFE) induced by proton‐pump inhibitors	2
Bullous pemphigoid in kidney transplant rejection: A case report and literature review	2